메뉴 건너뛰기




Volumn 173, Issue 4, 2012, Pages 251-257

Combined Therapy of Voriconazole and Anidulafungin in Murine Infections by Aspergillus flavus

Author keywords

Anidulafungin; Animal models; Antifungal combination; Aspergillus flavus; Fungal infection; Voriconazole

Indexed keywords

ANIDULAFUNGIN; ANTIFUNGAL AGENT; ECHINOCANDIN; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

EID: 84857900176     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9507-6     Document Type: Article
Times cited : (17)

References (33)
  • 1
    • 42349084468 scopus 로고    scopus 로고
    • Fungal infections in hematopoietic stem cell transplant recipients
    • Marr KA. Fungal infections in hematopoietic stem cell transplant recipients. Med Mycol. 2008; 46: 293-302.
    • (2008) Med Mycol , vol.46 , pp. 293-302
    • Marr, K.A.1
  • 5
    • 68849085666 scopus 로고    scopus 로고
    • Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination
    • Perkhofer S, Lass-Flörl C. Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination. Expert Opin Investig Drugs. 2009; 18: 1393-404.
    • (2009) Expert Opin Investig Drugs , vol.18 , pp. 1393-1404
    • Perkhofer, S.1    Lass-Flörl, C.2
  • 6
    • 79952321919 scopus 로고    scopus 로고
    • In vitro and in vivo efficacy of anidulafungin in murine infections by Aspergillus flavus
    • Calvo E, Pastor FJ, Mayayo E, Salas V, Guarro J. In vitro and in vivo efficacy of anidulafungin in murine infections by Aspergillus flavus. Antimicrob Agents Chemother. 2011; 55: 1290-2.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 1290-1292
    • Calvo, E.1    Pastor, F.J.2    Mayayo, E.3    Salas, V.4    Guarro, J.5
  • 7
    • 80052264675 scopus 로고    scopus 로고
    • Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo
    • Calvo E, Pastor FJ, Mayayo E, Guarro J. Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo. Int J Antimicrob Agents. 2011; 38: 360-3.
    • (2011) Int J Antimicrob Agents , vol.38 , pp. 360-363
    • Calvo, E.1    Pastor, F.J.2    Mayayo, E.3    Guarro, J.4
  • 8
    • 79958813535 scopus 로고    scopus 로고
    • Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi
    • Guarro J. Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi. J Antimicrob Chemother. 2011; 66: 1447-66.
    • (2011) J Antimicrob Chemother , vol.66 , pp. 1447-1466
    • Guarro, J.1
  • 9
    • 44849086424 scopus 로고    scopus 로고
    • Anidulafungin: experimental therapy of fungal infections in animal models
    • Pastor FJ, Guarro J. Anidulafungin: experimental therapy of fungal infections in animal models. Rev Iberoam Micol. 2008; 25: 119-23.
    • (2008) Rev Iberoam Micol , vol.25 , pp. 119-123
    • Pastor, F.J.1    Guarro, J.2
  • 10
    • 33750553597 scopus 로고    scopus 로고
    • The safety of anidulafungin
    • Vazquez JA. The safety of anidulafungin. Expert Opin Drug Saf. 2006; 5: 751-8.
    • (2006) Expert Opin Drug Saf , vol.5 , pp. 751-758
    • Vazquez, J.A.1
  • 11
    • 80053253460 scopus 로고    scopus 로고
    • Laboratory Clinical Standards Institute, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved Standard-Second Edition, Wayne, PA: Clinical and Laboratory Standards Institute
    • Laboratory Clinical Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard-Second Edition. CLSI document M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
    • (2008) CLSI Document M38-A2
  • 12
    • 1442300127 scopus 로고    scopus 로고
    • In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus
    • Dannaoui E, Lortholary O, Dromer F. In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob Agents Chemother. 2004; 48: 970-8.
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 970-978
    • Dannaoui, E.1    Lortholary, O.2    Dromer, F.3
  • 13
    • 0035162902 scopus 로고    scopus 로고
    • In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates
    • Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother. 2001; 45: 327-30.
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 327-330
    • Arikan, S.1    Lozano-Chiu, M.2    Paetznick, V.3    Rex, J.H.4
  • 14
    • 12744273574 scopus 로고    scopus 로고
    • Pharmacokinetics/pharmacodynamics of echinocandins
    • Theuretzbacher U. Pharmacokinetics/pharmacodynamics of echinocandins. Eur J Microbiol Infect Dis. 2004; 23: 805-12.
    • (2004) Eur J Microbiol Infect Dis , vol.23 , pp. 805-812
    • Theuretzbacher, U.1
  • 15
    • 33845356887 scopus 로고    scopus 로고
    • Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus
    • Warn PA, Sharp A, Mosquera J, Spickermann J, Schimitt-Hoffmann A, Heep M, Denning DW. Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus. J Antimicrob Chemother. 2006; 58: 1198-207.
    • (2006) J Antimicrob Chemother , vol.58 , pp. 1198-1207
    • Warn, P.A.1    Sharp, A.2    Mosquera, J.3    Spickermann, J.4    Schimitt-Hoffmann, A.5    Heep, M.6    Denning, D.W.7
  • 16
    • 0034042868 scopus 로고    scopus 로고
    • Effect of grapefruit juice on serum voriconazole concentrations in the mouse
    • Sugar AM, Liu XP. Effect of grapefruit juice on serum voriconazole concentrations in the mouse. Med Mycol. 2000; 38: 209-12.
    • (2000) Med Mycol , vol.38 , pp. 209-212
    • Sugar, A.M.1    Liu, X.P.2
  • 17
    • 27844502515 scopus 로고    scopus 로고
    • Safety and pharmacokinetics of coadministered voriconazole and anidulafungin
    • Dowell JA, Schranz J, Baruch A, Foster G. Safety and pharmacokinetics of coadministered voriconazole and anidulafungin. J Clin Pharmacol. 2005; 45: 1373-82.
    • (2005) J Clin Pharmacol , vol.45 , pp. 1373-1382
    • Dowell, J.A.1    Schranz, J.2    Baruch, A.3    Foster, G.4
  • 19
    • 0037379397 scopus 로고    scopus 로고
    • In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points
    • Shalit I, Shadkchan Y, Samra Z, Osherov N. In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points. Antimicrob Agents Chemother. 2003; 47: 1416-8.
    • (2003) Antimicrob Agents Chemother , vol.47 , pp. 1416-1418
    • Shalit, I.1    Shadkchan, Y.2    Samra, Z.3    Osherov, N.4
  • 21
    • 28444451092 scopus 로고    scopus 로고
    • In vitro activity of the echinocandins. How should it be evaluated?
    • Pastor FJ, Guarro J. In vitro activity of the echinocandins. How should it be evaluated? Rev Iberoam Micol. 2005; 22: 133-40.
    • (2005) Rev Iberoam Micol , vol.22 , pp. 133-140
    • Pastor, F.J.1    Guarro, J.2
  • 22
    • 0035991955 scopus 로고    scopus 로고
    • Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis
    • Kirkpatrick WR, Perea S, Coco BJ, Patterson TF. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother. 2002; 46: 2564-8.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 2564-2568
    • Kirkpatrick, W.R.1    Perea, S.2    Coco, B.J.3    Patterson, T.F.4
  • 24
    • 23044509903 scopus 로고    scopus 로고
    • In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp
    • Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrob Agents Chemother. 2005; 49: 3572-4.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 3572-3574
    • Philip, A.1    Odabasi, Z.2    Rodriguez, J.3    Paetznick, V.L.4    Chen, E.5    Rex, J.H.6    Ostrosky-Zeichner, L.7
  • 25
    • 42949173371 scopus 로고    scopus 로고
    • Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions
    • Perkhofer S, Jost D, Dierich MP, Lass-Flörl C. Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions. Antimicrob Agents Chemother. 2008; 52: 1873-5.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 1873-1875
    • Perkhofer, S.1    Jost, D.2    Dierich, M.P.3    Lass-Flörl, C.4
  • 27
    • 66149156458 scopus 로고    scopus 로고
    • Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin
    • van de Sande WW, Mathotten RA, ten Kate MT, van Vianen W, Tavakol M, Rijnders BJ, Bakker-Woudenberg IA. Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin. Antimicrob Agents Chemother. 2009; 53: 2005-13.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 2005-2013
    • van de Sande, W.W.1    Mathotten, R.A.2    Ten Kate, M.T.3    van Vianen, W.4    Tavakol, M.5    Rijnders, B.J.6    Bakker-Woudenberg, I.A.7
  • 28
    • 6444222945 scopus 로고    scopus 로고
    • Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis
    • Chandrasekar PH, Cutright JL, Manavathu EK. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis. Clin Microbiol Infect. 2004; 10: 925-8.
    • (2004) Clin Microbiol Infect , vol.10 , pp. 925-928
    • Chandrasekar, P.H.1    Cutright, J.L.2    Manavathu, E.K.3
  • 29
    • 24144486212 scopus 로고    scopus 로고
    • Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis
    • MacCallum DM, Whyte JA, Odds FC. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. Antimicrob Agents Chemother. 2005; 49: 3697-701.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 3697-3701
    • Maccallum, D.M.1    Whyte, J.A.2    Odds, F.C.3
  • 30
    • 34848878326 scopus 로고    scopus 로고
    • Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole
    • Gubler C, Wildi SM, Imhof A, Schneemann M, Müllhaupt B. Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole. Infection. 2007; 35: 364-6.
    • (2007) Infection. , vol.35 , pp. 364-366
    • Gubler, C.1    Wildi, S.M.2    Imhof, A.3    Schneemann, M.4    Müllhaupt, B.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.